Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Clinical trial NCT07029581 · RECRUITING

Trial details

NCT number: NCT07029581
Sponsor: ACADIA Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lewy Body Dementia Psychosis

Start date: 2025-08-06
Primary completion: 2028-02-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.